DOSSIER · 13F-HR · Q4 2025

Trails Edge Capital Partners, LP

$405M in tracked AUM across 23 positions as of Q4 2025.

TE
CIK 0002077247 · last filed Dec 31, 2025
Total AUM
$405M
as of Q4 2025
Holdings
23
positions
Whale Score
44
44
tracked
Activity
no data
changes this Q
AI Analysis · Q4 2025

Trails Edge Capital Partners, LP filed its latest 13F-HR for Q4 2025. See the latest holdings and position changes below.

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight
01
ACAD
ACADIA PHARMACEUTICALS INC
$38M1.4M9.4%
02
BRD1EUR
MIND MEDICINE MINDMED INC
$34M2.6M8.5%
03
PCVX
VAXCYTE INC
$34M737K8.4%
04
NRIX
NURIX THERAPEUTICS INC
$33M1.7M8.2%
05
LBRX
LB PHARMACEUTICALS INC
$31M1.4M7.7%
06
XENE
XENON PHARMACEUTICALS INC
$27M597K6.6%
07
IMCR
IMMUNOCORE HLDGS PLC
$24M683K5.9%
08
RCUS
ARCUS BIOSCIENCES INC
$22M916K5.4%
09
TYRA
TYRA BIOSCIENCES INC
$18M700K4.5%
10
NGNE
NEUROGENE INC
$16M785K4.0%

Filing history

2025Q4Dec 31
$405M
23 positionsView →